February 22, 2020
Cancer Drugs

Oncology/Cancer Drugs Market Pharmaceuticals & Healthcare Analysis 2025

This report studies the global Oncology/Cancer Drugs market status and forecast categorize the global Oncology/Cancer Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India, and Other regions (the Middle East & Africa, Central & South America). 

Companies Mentioned are:

Roche, Novartis, Celgene, Amgen, Johnson & Johnson, GlaxoSmithKline, Eli Lilly & Co, Pfizer, Merck & Co., Sanofi

Further, the market is segmented based on the applications, types and Geography area such as

Oncology/Cancer Drugs Market, by Types:

  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Others

Oncology/Cancer Drugs Market, by Applications:

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Others

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Oncology/Cancer Drugs Market from 2013 to 2018 (historical) 2019 to 2025 (forecasted), covering:

North America (United States, Canada, Mexico)

Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam)

Europe (Germany, France, UK, Italy, Russia, Rest of Europe)

Central & South America (Brazil, Rest of South America)

Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa, Other)

This independent 100-page report guarantees you will remain better informed than your competition. With over 150 tables and figures examining the Oncology/Cancer Drugs Market, the report gives you a visual, one-stop breakdown of the leading products, submarkets, and market leader’s market revenue forecasts as well as analysis to 2025. 

The study objectives are:

  • To analyze and research the global Oncology/Cancer Drugs market status and future forecast involving production, revenue, consumption, historical, and forecast.
  • To present the key Oncology/Cancer Drugs manufacturers, production, revenue, market share, SWOT analysis, and development plans in the next few years.
  • To segment the breakdown data by regions, types, manufacturers, and applications.
  • To analyze the global and key regions’ market potential and advantage, opportunity and challenge, restraints, and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To strategically analyze each submarket concerning individual growth trend and their contribution to the market.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Table of Content:

Chapter 1-Oncology/Cancer Drugs Market Overview

Chapter 2- Global Oncology/Cancer Drugs Market Competition by Manufacturers

Chapter 3-Global Oncology/Cancer Drugs Market Capacity, Production, Revenue (Value) by Region (2017-2022)

Chapter 4-Global Oncology/Cancer Drugs Market Supply (Production), Consumption, Export, Import by Region (2017-2022)

Chapter 5-Global Oncology/Cancer Drugs Market Production, Revenue (Value), Price Trend by Type

Chapter 6-Global Oncology/Cancer Drugs Market Analysis by Application

Chapter 7-Marketing Strategy Analysis, Distributors/Traders

In this study, the years considered to estimate the market size of Oncology/Cancer Drugs:

 History Year: 2013-2017

 Base Year: 2017

 Estimated Year: 2018

 Forecast Year 2018 to 2025

 For the data information by region, company, type, and application, 2017 are considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.